Mechanism
How Dupilumab works
Blocks the IL-4 receptor alpha subunit, inhibiting both IL-4 and IL-13 signaling pathways involved in type 2 inflammation.
Class, mechanism, indications, adverse effects, kinetics, exam traps, and NBRC-style study pearls.
Dupilumab is a monoclonal antibody that blocks IL-4 receptor alpha signaling, reducing both IL-4 and IL-13 mediated inflammation. It is used for severe asthma, especially type 2 inflammatory disease, and is also widely used in atopic dermatitis and nasal polyps. Students should associate Dupilumab with IL-4 receptor blockade.
Mechanism
Blocks the IL-4 receptor alpha subunit, inhibiting both IL-4 and IL-13 signaling pathways involved in type 2 inflammation.
Clinical Pearl
Among asthma biologics, Dupilumab is the IL-4 receptor blocker.
Kinetics
Onset
Weeks
Peak
Variable
Duration
Long-term biologic therapy
NBRC-style question
A patient scenario involves severe asthma requiring biologic therapy. Which medication concept should the respiratory therapy student recognize?
High-yield answer
Dupilumab = Anti-IL-4Rα
Interactive practice
Master this medication through adaptive review of class, mechanism, indications, adverse effects, exam traps, and clinical scenarios. Missed concepts can later be surfaced for targeted remediation.
These are the answer choices, mechanisms, or medication classes most commonly confused with this medication on RT school and NBRC-style exams.
Related study paths
Use this medication page as a reference, then reinforce it with interactive practice and related PulmTools study resources.